Enter Note Done

Go to previous page in this tab

Session

General Poster Session
General Poster Session - Monday General Poster Session
Poster Hall (Halls D-E)

Set Timezone

Timezone

Type

Presentations

Presentation

General Poster Session

385-P - Effects of Ertugliflozin on Podocyte in High-Fat Diet–Induced Diabetic Kidney Disease Model, In Vivo and In Vitro [Board No. 385]

12:00pm-1:00pm Jun 6 (Central)

Hae Kyung Kim

Presentation

General Poster Session

1459-P - Human Islet Cell Transcriptome Analysis Using Single Nucleus RNA-seq Reveals New Beta-Cell Markers and Define Distinct Beta-Cell Subpopulations with Different Transcriptional Activity [Board No. 1459]

12:00pm-1:00pm Jun 6 (Central)

Randy Kang

Presentation

General Poster Session

394-P - Baseline Risk Markers and Visit-to-Visit Variability in Relation to Kidney Outcomes: A Post Hoc Analysis of the PERL Study [Board No. 394]

12:00pm-1:00pm Jun 6 (Central)

Viktor Rotbain Curovic

Presentation

General Poster Session

511-P - Perspective on Technology Training in Individuals with Type 1 Diabetes [Board No. 511]

12:00pm-1:00pm Jun 6 (Central)

Camille C Andre

Presentation

General Poster Session

512-P - Physician Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes: A U.S. Cross-Sectional Survey [Board No. 512]

12:00pm-1:00pm Jun 6 (Central)

John E Anderson

Presentation

General Poster Session

513-P - Diabetes Mobile Apps: A Resource for Inpatient Education and Support? [Board No. 513]

12:00pm-1:00pm Jun 6 (Central)

Jodi S Krall

Presentation

General Poster Session

515-P - Harnessing Simulation-Based Corrective Mentoring in Continuing Medical Education to Improve Clinical Decision Making and Identify Persisting Educational Needs [Board No. 515]

12:00pm-1:00pm Jun 6 (Central)

Robert A Esgro

Presentation

General Poster Session

516-P - A One-Year Curriculum for Diabetes Self-Management Education to Promote Lasting Lifestyle Changes [Board No. 516]

12:00pm-1:00pm Jun 6 (Central)

Hanaa Sallam

Presentation

General Poster Session

517-P - The Prevalence and Predictors of Improper Sharps Disposal among People with Diabetes in Saudi Arabia [Board No. 517]

12:00pm-1:00pm Jun 6 (Central)

Ghadah Alsuwailem

Presentation

General Poster Session

518-P - “What Can I Eat?” Healthy Choices for American Indians and Alaska Natives with T2D: Facilitators’ and Participants’ Voices from a Virtual Diabetes Nutrition Education Program [Board No. 518]

12:00pm-1:00pm Jun 6 (Central)

Sarah A Stotz

Presentation

General Poster Session

519-P - “What Can I Eat?” Healthy Choices for American Indians and Alaska Natives with T2D: Randomized Wait-List Controlled Trial Outcomes from a Nutrition Diabetes Education Program [Board No. 519]

12:00pm-1:00pm Jun 6 (Central)

Sarah A Stotz

Presentation

General Poster Session

521-P - Care Partner in Virtual Diabetes Self-Management Education and Support [Board No. 521]

12:00pm-1:00pm Jun 6 (Central)

Margaret Zupa

Presentation

General Poster Session

522-P - Qualitative Findings of a Culturally Tailored Rural Diabetes One-Day DSMES Program in Eastern Colorado [Board No. 522]

12:00pm-1:00pm Jun 6 (Central)

Tamara Oser

Presentation

General Poster Session

395-P - BeAM Value and Glycemia Assessed by Continuous Glucose Monitoring among Participants with Type 2 Diabetes and Chronic Kidney Disease [Board No. 395]

12:00pm-1:00pm Jun 6 (Central)

Laura Mayeda

Presentation

General Poster Session

523-P - The Results of Virtual Diabetic “Boot Camp” [Board No. 523]

12:00pm-1:00pm Jun 6 (Central)

Yi-Ju Chen

Presentation

General Poster Session

524-P - CME Activity Series Highlights Changes in Clinicians’ Knowledge and Competence about Novel Approaches to Reduce DKD Progression [Board No. 524]

12:00pm-1:00pm Jun 6 (Central)

Neha Agarwal

Presentation

General Poster Session

525-P - The Influence of Age of on the Weight Loss Outcome of Women in the National Diabetes Prevention Program [Board No. 525]

12:00pm-1:00pm Jun 6 (Central)

Meghana Ottur

Presentation

General Poster Session

526-P - e-Health Literacy Rates and Applicability of a Patient-Facing Mobile App Intervention in a Predominantly African-American and Latinx Cohort with Type 2 Diabetes [Board No. 526]

12:00pm-1:00pm Jun 6 (Central)

Savneet Kaur

Presentation

General Poster Session

527-P - Needs of mHealth Diabetes Services from Patients with Poorly Controlled Type 2 Diabetes Mellitus: A Qualitative Study [Board No. 527]

12:00pm-1:00pm Jun 6 (Central)

Qinqin Xie

Presentation

General Poster Session

528-P - Provider Perspectives: Digital Apps in Delivering Diabetes Self-Management Education and Support (DSMES) [Board No. 528]

12:00pm-1:00pm Jun 6 (Central)

Neha Mehrotra

Presentation

General Poster Session

529-P - Impact of Medication Adherence (MA) to Oral Glycemic Agents (OHAs) on Initiation of Dialysis in Patients with Moderately Impaired Renal Function [Board No. 529]

12:00pm-1:00pm Jun 6 (Central)

Yuta Yaguchi

Presentation

General Poster Session

530-P - Complex Diabetes Management in Primary Care: Confidence and Opportunities for Specialty Support [Board No. 530]

12:00pm-1:00pm Jun 6 (Central)

Carlos E Mendez

Presentation

General Poster Session

978-P - Rare Variants in Melanocortin 4 Receptor Gene (MC4R) Are Associated with Increased Visceral Fat and Altered Glucose Metabolism Independent of the Effect of Obesity in Children [Board No. 978]

12:00pm-1:00pm Jun 6 (Central)

Brittany Galuppo

Presentation

General Poster Session

979-P - Risk Factors for Hyperosmolar Hyperglycemic State in Youth-Onset Type 2 Diabetes [Board No. 979]

12:00pm-1:00pm Jun 6 (Central)

Lily Chao

Presentation

General Poster Session

396-P - Real-Life Evaluation of Sodium–Glucose Cotransporter 2 Inhibition in Type 1 Diabetes [Board No. 396]

12:00pm-1:00pm Jun 6 (Central)

Elisabeth Buur Stougaard

Presentation

General Poster Session

980-P - Continuous Glucose Monitor Improves Glycemic Control in Youth-Onset Type 2 Diabetes [Board No. 980]

12:00pm-1:00pm Jun 6 (Central)

Lily Chao

Presentation

General Poster Session

981-P - Gut Microbiome Profile of American Indian Children with Obesity and Comparison with Industrialized and Preindustrialized Microbiomes [Board No. 981]

12:00pm-1:00pm Jun 6 (Central)

Aleksandar Kostic

Presentation

General Poster Session

982-P - Perfect Storm in Mississippi: High Rate of Obesity Leading to Surge in Pediatric Diabetes during the COVID-19 Pandemic [Board No. 982]

12:00pm-1:00pm Jun 6 (Central)

Simeen Pasha

Presentation

General Poster Session

983-P - Prediabetes A1C Is Associated with Metabolic Disease in Girls with PCOS and Obesity [Board No. 983]

12:00pm-1:00pm Jun 6 (Central)

Erin Finn

Presentation

General Poster Session

984-P - Incidence of Cardiovascular Disease, Kidney Disease, and Death in Youth-Onset Type 2 Diabetes Before the Age of 20 Years: Eight-Year Follow-Up of Territory-Wide Surveillance in Hong Kong [Board No. 984]

12:00pm-1:00pm Jun 6 (Central)

Yingnan Fan

Presentation

General Poster Session

985-P - Prediction Models Combining Clinical Measures Identify Participants with Youth-Onset Diabetes Who Maintain Insulin Secretion [Board No. 985]

12:00pm-1:00pm Jun 6 (Central)

Maria Jose Redondo

Presentation

General Poster Session

986-P - Children with Type 2 Diabetes (T2D) Have Altered Arginine Metabolism [Board No. 986]

12:00pm-1:00pm Jun 6 (Central)

Mustafa Tosur

Presentation

General Poster Session

987-P - Cost-Effectiveness of a Diabetes Prevention Program among Latino Youth with Prediabetes [Board No. 987]

12:00pm-1:00pm Jun 6 (Central)

Micah Olson

Presentation

General Poster Session

988-P - Higher Environmental Pollution Burden Scores Associate with Lower Insulin Sensitivity in Minority Children with Overweight and Obesity [Board No. 988]

12:00pm-1:00pm Jun 6 (Central)

Karina Barragan

Presentation

General Poster Session

989-P - Impaired Coronary Arterial Dilation in Youth-Onset Type 2 Diabetes [Board No. 989]

12:00pm-1:00pm Jun 6 (Central)

Stephanie T Chung

Presentation

General Poster Session

397-P - eGFR Changes from Adolescence into Young Adulthood in Type 1 Diabetes: Evaluation of Novel eGFR Formulae [Board No. 397]

12:00pm-1:00pm Jun 6 (Central)

Funmbi Babalola

Presentation

General Poster Session

990-P - Prebiotics and Metformin: A Pilot Randomized Controlled Trial in Youth-Onset Type 2 Diabetes [Board No. 990]

12:00pm-1:00pm Jun 6 (Central)

Stephanie T Chung

Presentation

General Poster Session

991-P - Metformin Plasma Concentration as a Biomarker of Treatment Responsiveness in Youth-Onset Type 2 Diabetes [Board No. 991]

12:00pm-1:00pm Jun 6 (Central)

Katrina B Dietsche

Presentation

General Poster Session

992-P - Pediatric Diabetes Providers Are Poorly Adherent to the ADA Treatment Guidelines for New-Onset Type 2 Diabetes (T2D) [Board No. 992]

12:00pm-1:00pm Jun 6 (Central)

Jeries H Said

Presentation

General Poster Session

993-P - Cell-Free DNA Methylation as a Biomarker of Islet-Cell Death in Youth with Type 2 Diabetes [Board No. 993]

12:00pm-1:00pm Jun 6 (Central)

Lisa R Staimez

Presentation

General Poster Session

994-P - DINAMO—Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents with Type 2 Diabetes (T2D): Innovative Study Design and Baseline Characteristics [Board No. 994]

12:00pm-1:00pm Jun 6 (Central)

Lori M Laffel

Presentation

General Poster Session

995-P - LRG1 Mediates Diet-Induced Hyperinsulinemia by Enhancing Glucose-Stimulated Insulin Secretion [Board No. 995]

12:00pm-1:00pm Jun 6 (Central)

Desirae Morales

Presentation

General Poster Session

996-P - Systolic Blood Pressure (BP) Is Associated with Carotid Intima-Media Thickness (CIMT) Independently of Type 2 Diabetes Predisposition in Minority Children [Board No. 996]

12:00pm-1:00pm Jun 6 (Central)

Velia Nunez

Presentation

General Poster Session

997-P - TG/HDL Ratio as a Predictor of Insulin Resistance in U.S. Adolescents: Do Age and Sex Percentiles Matter? [Board No. 997]

12:00pm-1:00pm Jun 6 (Central)

Donna Eng

Presentation

General Poster Session

998-P - Association between Modifiable Lifestyle Behaviors and Prediabetes among Latino Adolescents with Obesity [Board No. 998]

12:00pm-1:00pm Jun 6 (Central)

Luis A. Rodriguez

Presentation

General Poster Session

999-P - Associations between Perceived Stress and Morning Serum Cortisol with Glycemic Measures in Minority Youth with Overweight or Obesity [Board No. 999]

12:00pm-1:00pm Jun 6 (Central)

Kimberly Felix

Presentation

General Poster Session

398-P - KIM-1 and TNFR 1 and Associations with Early Diabetic Nephropathy Histology [Board No. 398]

12:00pm-1:00pm Jun 6 (Central)

Frances Tian

Presentation

General Poster Session

1000-P - The Effects of Neighborhood Characteristics on Youth with Type 2 Diabetes Mellitus [Board No. 1000]

12:00pm-1:00pm Jun 6 (Central)

Jennifer Ni

Presentation

General Poster Session

1001-P - BMI Changes in Youth with Type 2 Diabetes during COVID-19 Shelter-in-Place: The Role of Neighborhood Risk Factors [Board No. 1001]

12:00pm-1:00pm Jun 6 (Central)

Jennifer Ni

Presentation

General Poster Session

1002-P - Implementing Continuous Glucose Monitoring in Children with Type 2 Diabetes [Board No. 1002]

12:00pm-1:00pm Jun 6 (Central)

Jacquelyn A Manfredo

Presentation

General Poster Session

1003-P - Incidence of Severe Diabetic Ketoacidosis among Children with Type 1 Diabetes Mellitus Prior to and During COVID-19 Pandemic: A Meta-analysis [Board No. 1003]

12:00pm-1:00pm Jun 6 (Central)

Osamah Alfayez

Presentation

General Poster Session

1004-P - Executive Dysfunction Predicts Lower Self-Care Readiness in Teens with Type 1 Diabetes [Board No. 1004]

12:00pm-1:00pm Jun 6 (Central)

Rebecca J Vitale

Presentation

General Poster Session

1005-P - A Multimodel Model Predictive Controller Can Improve Glucose Control in Children with Type 1 Diabetes (T1D) [Board No. 1005]

12:00pm-1:00pm Jun 6 (Central)

Emilie Palisaitis

Presentation

General Poster Session

1006-P - Differences in Diabetes Technology Use Only Partially Explain Disparities in Type 1 Diabetes Outcomes in Minority Youth [Board No. 1006]

12:00pm-1:00pm Jun 6 (Central)

Mary Pat Gallagher

Presentation

General Poster Session

1007-P - Health Disparities in the Effect of the COVID-19 Pandemic on Loss-to-Follow-Up Rates among High-Risk Pediatric Patients with Type 1 Diabetes (T1D) [Board No. 1007]

12:00pm-1:00pm Jun 6 (Central)

Meenal Gupta

Presentation

General Poster Session

1008-P - Trends in Improvement in Clinical Outcomes and Health Care Access in Underrepresented Youth with Type 1 Diabetes (T1D) [Board No. 1008]

12:00pm-1:00pm Jun 6 (Central)

David V Wagner

Presentation

General Poster Session

1009-P - The Association between Patient Characteristics and the Efficacy of Remote Patient Monitoring and Messaging [Board No. 1009]

12:00pm-1:00pm Jun 6 (Central)

Johannes Ferstad

Presentation

General Poster Session

399-P - Associations among Biomarkers of Inflammation, Tubular Injury, and Lipid Metabolism with Gestational Diabetes Mellitus (GDM) Status, Microalbuminuria, and Retinopathy in the MARIGOLD Study [Board No. 399]

12:00pm-1:00pm Jun 6 (Central)

Hongyan Liu

Presentation

General Poster Session

1010-P - Diabetes Distress in Younger vs. Older Emerging Adults: Confirmation of Content Validity of the Problem Areas in Diabetes—Emerging Adult Survey (PAID-EA) [Board No. 1010]

12:00pm-1:00pm Jun 6 (Central)

Katherine Wentzell

Presentation

General Poster Session

1011-P - School-Day Routines Positively Impact Time in Range for Children with Type 1 Diabetes [Board No. 1011]

12:00pm-1:00pm Jun 6 (Central)

Christine March

Presentation

General Poster Session

1012-P - Neighborhood Disadvantage, Childhood Opportunity Index, and Glycemic Control for Children with Type 1 Diabetes? [Board No. 1012]

12:00pm-1:00pm Jun 6 (Central)

Megan B Coriell

Presentation

General Poster Session

1013-P - Risk Factors for Hyperglycemic and Hyperketotic Emergencies in COVID+ Youth with Type 1 Diabetes (T1D) [Board No. 1013]

12:00pm-1:00pm Jun 6 (Central)

Sarah Tsai

Presentation

General Poster Session

1014-P - Characteristics Associated with Diabetes Device Use Before and During the Pandemic in Youth with T1D [Board No. 1014]

12:00pm-1:00pm Jun 6 (Central)

Charlotte Chen

Presentation

General Poster Session

1015-P - Disparities in CGM Uptake and Sustained Use among Youth with Type 1 Diabetes [Board No. 1015]

12:00pm-1:00pm Jun 6 (Central)

Jody Grundman

Presentation

General Poster Session

1016-P - Equitable Glycemic Improvement in Youth with T1D during COVID-19 [Board No. 1016]

12:00pm-1:00pm Jun 6 (Central)

Sando Ojukwu

Presentation

General Poster Session

1017-P - Relationship between Parent Fear of Hypoglycemia and Diabetes Family Conflict in Adolescents with Type 1 Diabetes [Board No. 1017]

12:00pm-1:00pm Jun 6 (Central)

Hannah Manis

Presentation

General Poster Session

1019-P - Predictors of Response to Metformin in Youth with Type 1 Diabetes (T1D) and Increased BMI [Board No. 1019]

12:00pm-1:00pm Jun 6 (Central)

Heba M Ismail

Presentation

General Poster Session

1020-P - Racial Disparity in Glycemic Outcome during Real-World Use of an Advanced Hybrid Closed-Loop System (AHCL) among Youth with Type 1 Diabetes (T1D) [Board No. 1020]

12:00pm-1:00pm Jun 6 (Central)

Nicholas J Christakis

Presentation

General Poster Session

400-P - More Pronounced Effect of Empagliflozin-Losartan Combination Therapy on Measured GFR and Blood Pressure vs. Either of the Drugs: A Crossover RCT in People with Type 2 Diabetes [Board No. 400]

12:00pm-1:00pm Jun 6 (Central)

Daniël van Raalte

Presentation

General Poster Session

1021-P - Telehealth Benefits among Latinx Adolescents and Young Adults (AYA) with Type 1 Diabetes (T1D) [Board No. 1021]

12:00pm-1:00pm Jun 6 (Central)

Jaquelin J Flores Garcia

Presentation

General Poster Session

1022-P - Youth from High-Poverty Neighborhoods Demonstrate Higher HbA1c within Year after Diagnosis of T1D [Board No. 1022]

12:00pm-1:00pm Jun 6 (Central)

Elise S Tremblay

Presentation

General Poster Session

1023-P - Clusters of Depressive Symptoms and Glycemic Outcomes in Youth with Type 1 Diabetes (T1D) [Board No. 1023]

12:00pm-1:00pm Jun 6 (Central)

Amit Shapira

Presentation

General Poster Session

1024-P - Identification of Sex-Specific Cytokine and Viral Infection Profiles in Type 1 Diabetes Patients [Board No. 1024]

12:00pm-1:00pm Jun 6 (Central)

Khyati Girdhar

Presentation

General Poster Session

1025-P - Racial Disparities in Diabetes Distress and Technology Use in Adolescents with Type 1 Diabetes [Board No. 1025]

12:00pm-1:00pm Jun 6 (Central)

Annabelle Wilcox

Presentation

General Poster Session

1026-P - Retrospective Analysis of Caregiver Health Management Competence during an Occupation Therapy Coaching Telehealth Intervention [Board No. 1026]

12:00pm-1:00pm Jun 6 (Central)

Julia Shin

Presentation

General Poster Session

1027-P - Access to Telemedicine and the Number of Medical Visits Pre- and Post-Lockdown in Latin American Children with Type 1 Diabetes [Board No. 1027]

12:00pm-1:00pm Jun 6 (Central)

Valeria Hirschler

Presentation

General Poster Session

1028-P - Acute Kidney Injury in Youth with Diabetes Admitted with Isolated Diabetic Ketoacidosis, Isolated Hyperglycemic Hyperosmolar State, and Hyperosmolar Diabetic Ketoacidosis: A Single Center Experience [Board No. 1028]

12:00pm-1:00pm Jun 6 (Central)

Erica Zarse

Presentation

General Poster Session

1029-P - INNOVATIONS: Improving Care of Patients with Type 1 Diabetes Mellitus through Utilization of Telemedicine and Outreach [Board No. 1029]

12:00pm-1:00pm Jun 6 (Central)

Virginia Purrington

Presentation

General Poster Session

1030-P - Glycemic Control Two Years after Diagnosis in Children with Type 1 Diabetes In Kuwait [Board No. 1030]

12:00pm-1:00pm Jun 6 (Central)

Taibah Alqaisi

Presentation

General Poster Session

401-P - Development of Predictive Models for Health Care Outcomes of Patients with Chronic Kidney Disease and Type 2 Diabetes [Board No. 401]

12:00pm-1:00pm Jun 6 (Central)

Rakesh Singh

Presentation

General Poster Session

1031-P - Psychosocial Problems in Indonesian Children and Adolescents with Type 1 Diabetes (T1D) during COVID-19 Pandemic [Board No. 1031]

12:00pm-1:00pm Jun 6 (Central)

Ghaisani Fadiana

Presentation

General Poster Session

1032-P - Improving CGM Uptake in Minority Youth and Youth with Poorly Controlled T1D [Board No. 1032]

12:00pm-1:00pm Jun 6 (Central)

Risa M Wolf

Presentation

General Poster Session

1033-P - An Interactive Capacity Planning Dashboard for Algorithm-Enabled Telemedicine-Based Diabetes Care [Board No. 1033]

12:00pm-1:00pm Jun 6 (Central)

Annette Chang

Presentation

General Poster Session

1034-P - No “Honeymoon” for Youth, in Particular Blacks, Diagnosed with Diabetes during the First Year of the COVID-19 Pandemic [Board No. 1034]

12:00pm-1:00pm Jun 6 (Central)

Nkeiruka Mkparu

Presentation

General Poster Session

1267-P - Fine-Mapping Type 1 Diabetes Risk at the MHC Locus [Board No. 1267]

12:00pm-1:00pm Jun 6 (Central)

Carolyn McGrail

Presentation

General Poster Session

1268-P - Underlying T Cell Receptor Methylation Defects in Type 1 Diabetes Associated with Quantitative Defects [Board No. 1268]

12:00pm-1:00pm Jun 6 (Central)

Denise L Faustman

Presentation

General Poster Session

1269-P - The Type 1 Diabetes Knowledge Portal: An Open-Access Resource for Insights into the Genetic and Genomic Basis of Type 1 Diabetes [Board No. 1269]

12:00pm-1:00pm Jun 6 (Central)

Maria C Costanzo

Presentation

General Poster Session

1270-P - ICA1 Is Differentially Methylated and Expressed in Familial Type 1 Diabetes [Board No. 1270]

12:00pm-1:00pm Jun 6 (Central)

Mohammed H Dashti

Presentation

General Poster Session

1271-P - The Gut Microbiota Related Genetic Variant at ABO Locus, Circulating Metabolome, and Type 2 Diabetes Risk: Prospective Study in UK Biobank [Board No. 1271]

12:00pm-1:00pm Jun 6 (Central)

Rui Tang

Presentation

General Poster Session

1272-P - Genomic Rearrangement in Noncoding Region of Chromosome 1 Leads to Spontaneous Obesity and Type 2 Diabetes [Board No. 1272]

12:00pm-1:00pm Jun 6 (Central)

Donnell White, III

Presentation

General Poster Session

402-P - Machine Learning Approach to Evaluate the Prospective Kidney Failure Risk of the Complement Proteome in T1D [Board No. 402]

12:00pm-1:00pm Jun 6 (Central)

Zaipul Md Dom

Presentation

General Poster Session

1273-P - The Interplay between Polygenic and Rare HNF1A Variant Risk in Type 2 Diabetes [Board No. 1273]

12:00pm-1:00pm Jun 6 (Central)

Lauren Stalbow

Presentation

General Poster Session

1274-P - Prevalence and Clinical Characteristics of Monogenic Diabetes in Chinese Population [Board No. 1274]

12:00pm-1:00pm Jun 6 (Central)

Sandra Tsoi

Presentation

General Poster Session

1276-P - Transancestral Genomic Analysis Links Dysregulation of Valine Metabolism to the Development of Heart Failure in Type 2 Diabetes [Board No. 1276]

12:00pm-1:00pm Jun 6 (Central)

Yaling Tang

Presentation

General Poster Session

1277-P - Spatial Whole Transcriptome Profiling of the Human Pancreas Uncovers Unique Insights into Histological Structures [Board No. 1277]

12:00pm-1:00pm Jun 6 (Central)

Meghan F Hogan

Presentation

General Poster Session

1278-P - The Tale of Caveolin 1 rs1997623 Variant in Obesity and Metabolic Syndrome [Board No. 1278]

12:00pm-1:00pm Jun 6 (Central)

Ashraf Al Madhoun

Presentation

General Poster Session

1279-P - Caveolin 1 rs1997623 Is Associated with Metabolic Syndrome in Arab Adult Individuals from Kuwait [Board No. 1279]

12:00pm-1:00pm Jun 6 (Central)

Ashraf Al Madhoun

Presentation

General Poster Session

1280-P - Use of Machine Learning to Determine the Relative Influence (RI) of Genetic Risk Scores of 11 Glycemic Traits on Myocardial Infarction and Stroke in 409,633 Participants in the UK Biobank [Board No. 1280]

12:00pm-1:00pm Jun 6 (Central)

Harshal Deshmukh

Presentation

General Poster Session

1281-P - Understanding the Interaction between Type 2 Diabetes and COVID-19 via Extracellular Vesicle Proteomic and Phosphoproteomic Signatures [Board No. 1281]

12:00pm-1:00pm Jun 6 (Central)

Yury O Nunez Lopez

Presentation

General Poster Session

1282-P - Genetic Susceptibility of Dipeptidyl Peptidase-4 Inhibitor–Associated Bullous Pemphigoid in Chinese Patients with Type 2 Diabetes [Board No. 1282]

12:00pm-1:00pm Jun 6 (Central)

Juliana C Chan

Presentation

General Poster Session

1283-P - Paired Box 4 R192H (rs2233580) Variant Associated with Type 2 Diabetes Influenced the Response to the Treatment with Hypoglycemic Agents [Board No. 1283]

12:00pm-1:00pm Jun 6 (Central)

Nattachet Plengvidhya

Presentation

General Poster Session

403-P - Reduced Mitochondrial DNA Copy Number in Type 1 Diabetes and Nephropathy and Correlates Thereof [Board No. 403]

12:00pm-1:00pm Jun 6 (Central)

Alicia Jenkins

Presentation

General Poster Session

1284-P - Genetic and Lifestyle Associations with Cardiometabolic Traits and Diabetes Risk Factors in Ethnically Diverse Africans [Board No. 1284]

12:00pm-1:00pm Jun 6 (Central)

Sarah A Tishkoff

Presentation

General Poster Session

1285-P - Differentiating between Diabetic and Idiopathic Gastroparesis: A Genetic Perspective [Board No. 1285]

12:00pm-1:00pm Jun 6 (Central)

Sandra P Smieszek

Presentation

General Poster Session

1388-P - Pancreatic Neural Circuitry in Obesity and Diabetes [Board No. 1388]

12:00pm-1:00pm Jun 6 (Central)

Rollie F Hampton

Presentation

General Poster Session

1389-P - Asprosin-Neutralizing Antibodies as a Treatment for Binge Eating [Board No. 1389]

12:00pm-1:00pm Jun 6 (Central)

Jerney Harms

Presentation

General Poster Session

1390-P - FOXO1 Promotes Sexually Dimorphic Effects on Energy Balance in the Preoptic Anterior Hypothalamus [Board No. 1390]

12:00pm-1:00pm Jun 6 (Central)

Valeria C Torres Irizarry

Presentation

General Poster Session

1391-P - Reduced DMPC and PMPC in Lung Surfactant Promotes SARS-CoV-2 Infection in Obesity [Board No. 1391]

12:00pm-1:00pm Jun 6 (Central)

Kang Du

Presentation

General Poster Session

1392-P - Gut Microbiota Contributes to the Beneficial Metabolic Effects of Gelesis Hydrogel Technology [Board No. 1392]

12:00pm-1:00pm Jun 6 (Central)

Bryan W Jones

Presentation

General Poster Session

1393-P - Cardiac and Skeletal Muscles Exhibit Discordant Flux Adaptations as a Result of Western Diet–Induced Obesity [Board No. 1393]

12:00pm-1:00pm Jun 6 (Central)

Deveena R Banerjee

Presentation

General Poster Session

1394-P - Peri-Islet Glial-Cell Expansion Occurs in Response to High-Fat Diet-Induced Obesity and Hyperglycemia [Board No. 1394]

12:00pm-1:00pm Jun 6 (Central)

Jingjing Niu

Presentation

General Poster Session

1395-P - The Role of Adipocyte Connexin-43 in Mediating Adipose Tissue Inflammation and Dysfunction in Obesity [Board No. 1395]

12:00pm-1:00pm Jun 6 (Central)

Amir Tirosh

Presentation

General Poster Session

386-P - ROCK1 Regulation of AMPK in the Development of Diabetic Nephropathy [Board No. 386]

12:00pm-1:00pm Jun 6 (Central)

Yosuke Nagai

Presentation

General Poster Session

404-P - Relationships among Triglyceride (TG) Concentrations across Lipoprotein Subclasses, Intraglomerular Hemodynamics, and Kidney Oxygen Availability in Adolescents with Type 1 Diabetes (T1D) [Board No. 404]

12:00pm-1:00pm Jun 6 (Central)

Meghan E Pauley

Presentation

General Poster Session

1396-P - Critical Cellular Functions That Mediate the Early Stages of Adipogenesis Are Directly Influenced by 14-3-3zeta and Its Interactome [Board No. 1396]

12:00pm-1:00pm Jun 6 (Central)

Sabri Ahmed Rial

Presentation

General Poster Session

1397-P - A Cocoa Butter–Based Ketogenic Diet Fails to Improve Glucose Homeostasis and Promote Weight Loss in Obese Mice [Board No. 1397]

12:00pm-1:00pm Jun 6 (Central)

Amanda A Greenwell

Presentation

General Poster Session

1398-P - Lactobacillus rhamnosus Attenuates Depressive-Like Behavior in High-Fat Diet Fed Mice and Regulates Tyrosine Hydroxylase [Board No. 1398]

12:00pm-1:00pm Jun 6 (Central)

Mareike Schell

Presentation

General Poster Session

1399-P - Quantitation of the Energy Cost of Physical Activity in Mice [Board No. 1399]

12:00pm-1:00pm Jun 6 (Central)

Vojtech Skop

Presentation

General Poster Session

1400-P - Endothelial Cell Autophagy Contributes to HFD-Induced Obesity and Insulin Resistance in Mice [Board No. 1400]

12:00pm-1:00pm Jun 6 (Central)

Guang Ren

Presentation

General Poster Session

1401-P - Long-Term Metabolic Effects of Noncaloric Sweeteners [Board No. 1401]

12:00pm-1:00pm Jun 6 (Central)

Amir Tirosh

Presentation

General Poster Session

1402-P - Endogenous Erythropoietin Is Protective in Mice during High-Fat Diet to Obesity and Cardiac Function while Exogenous Erythropoietin Exacerbates Cardiac Function [Board No. 1402]

12:00pm-1:00pm Jun 6 (Central)

Heather Rogers

Presentation

General Poster Session

1403-P - DA-1726, a Balanced GLP1R/GCGR Dual Agonist, Effectively Controls Both Body Weight and Blood Glucose [Board No. 1403]

12:00pm-1:00pm Jun 6 (Central)

Yuna Chae

Presentation

General Poster Session

1404-P - High Cardiorespiratory Fitness Exerts Metabolic Protection in Obese Rats Regardless of Caloric Restriction or Short-Term Exercise [Board No. 1404]

12:00pm-1:00pm Jun 6 (Central)

Chanisa Thonusin

Presentation

General Poster Session

1405-P - Bacteroides thetaiotaomicron Fortifies the Gut Mucosa and Improves Host Metabolism in Dietary Obese Mice [Board No. 1405]

12:00pm-1:00pm Jun 6 (Central)

Jennifer Lee

Presentation

General Poster Session

405-P - Glycemic Control Impacts Renal Function Decline among People with Type 1 Diabetes after the Onset of Diabetic Kidney Disease [Board No. 405]

12:00pm-1:00pm Jun 6 (Central)

Hetal Shah

Presentation

General Poster Session

1406-P - ZP8396, a Novel Amylin Analogue, Induces Weight Loss in DIO Rats with a Formulation Space at Physiological pH [Board No. 1406]

12:00pm-1:00pm Jun 6 (Central)

Jolanta Skarbaliene

Presentation

General Poster Session

1407-P - Deletion of the Abi3 Immune Gene Locus in Mice Results in Obesity and Systemic Metabolic Disruption [Board No. 1407]

12:00pm-1:00pm Jun 6 (Central)

Daniel C Smith

Presentation

General Poster Session

1408-P - Acute Aerobic Exercise Unveils Serum Metabolomics Markers That Distinguish Overweight and Healthy Weight Individuals [Board No. 1408]

12:00pm-1:00pm Jun 6 (Central)

Alisa B Nelson

Presentation

General Poster Session

1409-P - Revealing Heterogeneity in Human White Adipose Tissue at Single-Cell Level [Board No. 1409]

12:00pm-1:00pm Jun 6 (Central)

Vissarion Efthymiou

Presentation

General Poster Session

1410-P - Changes in Circulating MicroRNA-193b and Long-Term Successful Weight Loss in Response to Dietary and Lifestyle Interventions: The POUNDS Lost and CENTRAL Trials [Board No. 1410]

12:00pm-1:00pm Jun 6 (Central)

Yoriko Heianza

Presentation

General Poster Session

1411-P - Increased 24-Hour Plasma Free Fatty Acids in People with Obesity and Prediabetes [Board No. 1411]

12:00pm-1:00pm Jun 6 (Central)

Max C Petersen

Presentation

General Poster Session

1412-P - Preexisting Nonalcoholic Steatohepatitis Attenuates Improvement of Adipose Tissue OXPHOS Capacity after Weight-Loss Surgery [Board No. 1412]

12:00pm-1:00pm Jun 6 (Central)

Nina Saatmann

Presentation

General Poster Session

1413-P - Semaglutide 2.4 mg Improved Glucose Metabolism and Reverted Prediabetes to Normoglycemia in Adults with Overweight/Obesity vs. Liraglutide 3.0 mg (STEP 8) [Board No. 1413]

12:00pm-1:00pm Jun 6 (Central)

Julio Rosenstock

Presentation

General Poster Session

1414-P - Dapagliflozin Protects Human Cardiac Progenitor Cells from Deleterious Effects of the Secretome from Visceral Adipose Cells of Obese Subjects [Board No. 1414]

12:00pm-1:00pm Jun 6 (Central)

Francesco Giorgino

Presentation

General Poster Session

1415-P - Risk–Benefit Data from the Worldwide EndoBarrier (EB) Registry [Board No. 1415]

12:00pm-1:00pm Jun 6 (Central)

Robert E Ryder

Presentation

General Poster Session

406-P - Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes—A Randomized, Double-Blind, Placebo-Controlled Trial [Board No. 406]

12:00pm-1:00pm Jun 6 (Central)

Ninna H Tougaard

Presentation

General Poster Session

1416-P - UK First National Health Service (NHS) Endobarrier (EB) Service for Uncontrolled Diabesity: Four-Year Outcomes for All 62 Treated Patients [Board No. 1416]

12:00pm-1:00pm Jun 6 (Central)

Robert E Ryder

Presentation

General Poster Session

1417-P - Gut Microbiome Translocation to Visceral Adipose Tissue Promotes Recruitment of Adipose-Specific Neutrophils in Human Obesity [Board No. 1417]

12:00pm-1:00pm Jun 6 (Central)

Dharti Shantaram

Presentation

General Poster Session

1418-P - Effect of Eight-Hour Time-Restricted Eating vs. Daily Calorie Restriction on Cardiovascular Disease Risk Factors in Adults with Obesity [Board No. 1418]

12:00pm-1:00pm Jun 6 (Central)

Shuhao Lin

Presentation

General Poster Session

1419-P - Insulin Resistance Predicts Severe Acute COVID-19 and Long COVID [Board No. 1419]

12:00pm-1:00pm Jun 6 (Central)

Tracey McLaughlin

Presentation

General Poster Session

1420-P - Gestational Diabetes Glyburide Treatment and Glycemic Control: Associations with Risk of Subsequent Child Obesity [Board No. 1420]

12:00pm-1:00pm Jun 6 (Central)

Jami L Josefson

Presentation

General Poster Session

1421-P - Long-Term Type 2 Diabetes Remission after Bariatric Surgery in Patients with and without Liver Steatosis [Board No. 1421]

12:00pm-1:00pm Jun 6 (Central)

Anne Lautenbach

Presentation

General Poster Session

1422-P - The Potential of Semaglutide Once-Weekly in Patients without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss after Bariatric Surgery [Board No. 1422]

12:00pm-1:00pm Jun 6 (Central)

Anne Lautenbach

Presentation

General Poster Session

1423-P - Endoscopic Revision for Post-Bariatric Weight Regain Results in Less Weight Loss in People with Type 2 Diabetes [Board No. 1423]

12:00pm-1:00pm Jun 6 (Central)

Sanaa Tejani

Presentation

General Poster Session

1424-P - Impact of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in Obese Patients with Type 2 Diabetes: Prospective Observational Study [Board No. 1424]

12:00pm-1:00pm Jun 6 (Central)

Yuki Oe

Presentation

General Poster Session

1425-P - Effect of Ghrelin on Glucose Tolerance after Sleeve Gastrectomy [Board No. 1425]

12:00pm-1:00pm Jun 6 (Central)

Nora Hedbäck

Presentation

General Poster Session

407-P - Skin Autofluorescence Is Associated with Tubular Injury Represented by Urinary Excretion of Liver-Type Fatty Acid–Binding Protein in People with Diabetes [Board No. 407]

12:00pm-1:00pm Jun 6 (Central)

Hiroki Yamagami

Presentation

General Poster Session

1426-P - Increased Insulin Secretion and Glucose Effectiveness Result in Improved Glucose Tolerance in Obese Subjects Two Months after Gastric Bypass and Sleeve [Board No. 1426]

12:00pm-1:00pm Jun 6 (Central)

Roberto Visentin

Presentation

General Poster Session

1427-P - Long-Term Treatment with Testosterone Leads to Profound Weight Loss in Men with Hypogonadism and Type 2 Diabetes: Update of Real-World Data from a Registry Study [Board No. 1427]

12:00pm-1:00pm Jun 6 (Central)

Farid Saad

Presentation

General Poster Session

1428-P - Monocyte Cholesterol Metabolism during Weight Loss and Glycemic Improvement [Board No. 1428]

12:00pm-1:00pm Jun 6 (Central)

Jingzhong Ding

Presentation

General Poster Session

1429-P - Metabolically Healthy Obese Is Actually Not Healthy but at Risk for Developing Diabetes Mellitus [Board No. 1429]

12:00pm-1:00pm Jun 6 (Central)

Satoru Mizushiri

Presentation

General Poster Session

1430-P - Association of Obesity and Diabetes with SARS-Cov-2 Infection and Symptoms [Board No. 1430]

12:00pm-1:00pm Jun 6 (Central)

Sharon Edelstein

Presentation

General Poster Session

1431-P - Development of a New Index Based on Preoperative Serum Lipocalin 2 to Predict Post-LSG Weight Reduction [Board No. 1431]

12:00pm-1:00pm Jun 6 (Central)

Shen Qu

Presentation

General Poster Session

1432-P - ALT Elevation Suggestive of NAFLD in Overweight and Obese Youth on Second-Generation Antipsychotics [Board No. 1432]

12:00pm-1:00pm Jun 6 (Central)

Nancy A Crimmins

Presentation

General Poster Session

1433-P - Comparative Weight Loss with GLP-1 Receptor Agonists vs. Bariatric Surgery in Obesity: A Systematic Review and Pair-Wise Meta-analysis [Board No. 1433]

12:00pm-1:00pm Jun 6 (Central)

Shohinee Sarma

Presentation

General Poster Session

1434-P - ANGPTL8 Variant R59W Is Associated with Increased Circulatory TNF-alpha and IL7 LEVELS and Inflammation [Board No. 1434]

12:00pm-1:00pm Jun 6 (Central)

Anwar Mohammad

Presentation

General Poster Session

1435-P - Identifying the Continuing Educational Needs of U.S. Physicians in Managing Patients with T2DM and Obesity [Board No. 1435]

12:00pm-1:00pm Jun 6 (Central)

Wendy Cerenzia

Presentation

General Poster Session

408-P - Fibrosis 4 Index Related to Microalbuminuria in Tibetan Patients with T2D and NAFLD [Board No. 408]

12:00pm-1:00pm Jun 6 (Central)

Chenghui Zhang

Presentation

General Poster Session

1436-P - Metformin Increases Skeletal Muscle Mitochondrial Function and Acute Phase Insulin Sensitivity in Obstructive Sleep Apnea [Board No. 1436]

12:00pm-1:00pm Jun 6 (Central)

Elizabeth RM Zunica

Presentation

General Poster Session

1437-P - Waist-to-Height Ratio Is a Better Indicator Instead of Waist Circumference for Diagnosing Metabolic Syndrome in Type 2 Diabetes [Board No. 1437]

12:00pm-1:00pm Jun 6 (Central)

Yilin Ma

Presentation

General Poster Session

1438-P - Association between Screen Time, Including That for Smartphones, and Overweight/Obesity among Children in Japan [Board No. 1438]

12:00pm-1:00pm Jun 6 (Central)

Izumi Ikeda

Presentation

General Poster Session

1439-P - Association between Sleep Duration, Bedtime, and Hyperglycemia or Overweight/Obesity among Japanese Children [Board No. 1439]

12:00pm-1:00pm Jun 6 (Central)

Haruka Shiozaki

Presentation

General Poster Session

1440-P - Effects of Two Weight-Loss Medications, Liraglutide and Orlistat, on Liver Enzymes in Patients with Overweight or Obesity in a Real-World Setting [Board No. 1440]

12:00pm-1:00pm Jun 6 (Central)

Juan J Gorgojo-Martinez

Presentation

General Poster Session

1441-P - Fidelity of BMI and Waist Circumference as Adiposity Measures in White and Black Adults [Board No. 1441]

12:00pm-1:00pm Jun 6 (Central)

Zhao Liu

Presentation

General Poster Session

1442-P - Association of Elevated Serum FABP1 with Hyperuricemia in Patients with Obesity and the Alteration after Sleeve Gastrectomy [Board No. 1442]

12:00pm-1:00pm Jun 6 (Central)

You Hui

Presentation

General Poster Session

1443-P - Real-Time In Vivo Analysis of Beta-Cell Autophagy in Autoimmune Diabetes [Board No. 1443]

12:00pm-1:00pm Jun 6 (Central)

Olha Melnyk

Presentation

General Poster Session

1444-P - Knockdown of Etv5 Impairs Viability of Pancreatic Beta Cells by Enhancing ROS Production [Board No. 1444]

12:00pm-1:00pm Jun 6 (Central)

Jochen Seufert

Presentation

General Poster Session

1445-P - Ogt Is Dispensable for Beta-Cell Development but Essential for Postnatal Beta-Cell Identity Maintenance via Pdx1 [Board No. 1445]

12:00pm-1:00pm Jun 6 (Central)

Alicia L Wong

Presentation

General Poster Session

409-P - Long-Term Testosterone Treatment Improves Estimated Glomerular Filtration Rate (eGFR) in Men with Hypogonadism and Type 2 Diabetes Mellitus: Update of Registry Data [Board No. 409]

12:00pm-1:00pm Jun 6 (Central)

Farid Saad

Presentation

General Poster Session

1446-P - Sex-Specific Effects of Nr4a1 in the Pancreatic Beta Cell [Board No. 1446]

12:00pm-1:00pm Jun 6 (Central)

Jeffery S Tessem

Presentation

General Poster Session

1447-P - The Snd1 Coregulator Controls ß-Cell Function [Board No. 1447]

12:00pm-1:00pm Jun 6 (Central)

Sukrati kanojia

Presentation

General Poster Session

1448-P - Partial Pancreatectomy Increased α-Cell Volume Density, but Not Compensated ß-Cell Volume in Japanese Subjects [Board No. 1448]

12:00pm-1:00pm Jun 6 (Central)

Yuki Takeuchi

Presentation

General Poster Session

1449-P - Reducing Ghrelin Levels as a Novel Method to Increase Pancreatic Beta-Cell Mass [Board No. 1449]

12:00pm-1:00pm Jun 6 (Central)

Deepali Gupta

Presentation

General Poster Session

1450-P - Identifying Hidden Sources of Tissue Plasticity in Pancreatic Islets with a Novel Multicolor Flow Cytometry Approach [Board No. 1450]

12:00pm-1:00pm Jun 6 (Central)

Jan Czyzyk

Presentation

General Poster Session

1451-P - Peri-Islet Fibrosis in Cystic Fibrosis Is Associated with Altered Alpha-Cell Phenotype [Board No. 1451]

12:00pm-1:00pm Jun 6 (Central)

Nicole Kattner

Presentation

General Poster Session

1452-P - PDX1 and CK19 as Markers of Cell Maturation in the Human Pancreas [Board No. 1452]

12:00pm-1:00pm Jun 6 (Central)

Alexandra Proshchina

Presentation

General Poster Session

1453-P - Possible Delta- to Beta-Cell Transdifferentiation in Aged Diabetic Mutant CRY1 Transgenic Mice [Board No. 1453]

12:00pm-1:00pm Jun 6 (Central)

Satoshi Okano

Presentation

General Poster Session

1454-P - A Transcriptomic Signature of Pancreatic Islet Leader Beta Cells [Board No. 1454]

12:00pm-1:00pm Jun 6 (Central)

Pauline L Chabosseau

Presentation

General Poster Session

1455-P - The Loss of Pancreatic ß-Cell Complement 1q-Like-3 Secreted Protein Increases Insulin Secretion in Lean and Obese Mice [Board No. 1455]

12:00pm-1:00pm Jun 6 (Central)

Mostafizur Rahman

Presentation

General Poster Session

410-P - Preoperative Diabetes Optimization and Clinical Outcomes [Board No. 410]

12:00pm-1:00pm Jun 6 (Central)

Carlos E Mendez

Presentation

General Poster Session

1456-P - Molecular Architecture of AR Action in Insulin Secretion in Male Pancreatic ß-Cells [Board No. 1456]

12:00pm-1:00pm Jun 6 (Central)

Paula Mota de Sa

Presentation

General Poster Session

1457-P - Cholesterol Accumulation in Islets Increases Steroidogenic Acute Regulatory (StAR) Protein Expression and Decreases Islet Cell Viability and ß-Cell Function [Board No. 1457]

12:00pm-1:00pm Jun 6 (Central)

Rehana Akter

Presentation

General Poster Session

1458-P - Lipophagy Is Constitutively Active in Pancreatic Beta Cells and Maintains Insulin Secretion [Board No. 1458]

12:00pm-1:00pm Jun 6 (Central)

Yumi Imai

Presentation

General Poster Session

1460-P - Tauroursodeoxycholic Acid (tudca) Improves the Morphofunction of Pancreatic Beta Cells in Postweaning Protein-Restricted Mice [Board No. 1460]

12:00pm-1:00pm Jun 6 (Central)

Lohanna M Barreto Dos Santos

Presentation

General Poster Session

1461-P - Quantifying Proinsulin Misfolding in the Endoplasmic Reticulum [Board No. 1461]

12:00pm-1:00pm Jun 6 (Central)

Anoop Arunagiri

Presentation

General Poster Session

1462-P - Effect of Energy Restriction on the Intracellular Metabolism of Rodent Pancreatic ß-Cells In Vitro and Obese Mice [Board No. 1462]

12:00pm-1:00pm Jun 6 (Central)

Koki Chiba

Presentation

General Poster Session

1463-P - Steroidogenic Factor 1 in ß cells Moonlights as a Brake on Glucose Intolerance in Obesity [Board No. 1463]

12:00pm-1:00pm Jun 6 (Central)

Yan Guo

Presentation

General Poster Session

1464-P - Computational Modeling for Design of Next Generation Microphysiological Systems for Evaluation of ß-Cell Health and Function [Board No. 1464]

12:00pm-1:00pm Jun 6 (Central)

Emma Vanderlaan

Presentation

General Poster Session

1465-P - Metabolic Remodeling in Pancreatic Beta Cells in Japanese Patients with Type 2 Diabetes [Board No. 1465]

12:00pm-1:00pm Jun 6 (Central)

Rimi Izumihara

Presentation

General Poster Session

411-P - Potential to Utilize DNA Methylation as a Biomarker to Predict Major Coronary Artery Disease (CAD) Risk in Type 1 Diabetes (T1D) [Board No. 411]

12:00pm-1:00pm Jun 6 (Central)

Rachel G Miller

Presentation

General Poster Session

1466-P - Pancreatic Delta Cells Switched Islet's Ca2+ Oscillation Modes by Inhibiting Endogenous Glucagon from Alpha Cells [Board No. 1466]

12:00pm-1:00pm Jun 6 (Central)

Huixia Ren

Presentation

General Poster Session

1467-P - Chemical Profiles of Acinar Tissue and Pancreatic Islets from Healthy and T2D-Affected Pancreata [Board No. 1467]

12:00pm-1:00pm Jun 6 (Central)

Jonathan V Sweedler

Presentation

General Poster Session

1468-P - Effect of Kcnq1ot1 on Influencing the Function of Pancreatic ß-Cells Targeting miR-92a-1-5p [Board No. 1468]

12:00pm-1:00pm Jun 6 (Central)

Yalan Chen

Presentation

General Poster Session

1469-P - Inhibition of the Integrated Stress Response Increases PD-L1 in Islet ß-Cells and Protects against Autoimmune Diabetes [Board No. 1469]

12:00pm-1:00pm Jun 6 (Central)

Fei Huang

Presentation

General Poster Session

1470-P - GABA Stimulates or Inhibits Insulin and Somatostatin Secretion in Human Pancreatic Islets Depending on Glucose Concentration [Board No. 1470]

12:00pm-1:00pm Jun 6 (Central)

Sandra Mara Ferreira

Presentation

General Poster Session

1472-P - Dual Pancreatic Adrenergic and Dopaminergic Signaling as a Therapeutic Mechanism for Treatment of Dysglycemia by Bromocriptine [Board No. 1472]

12:00pm-1:00pm Jun 6 (Central)

Zachary Freyberg

Presentation

General Poster Session

1473-P - Combination Therapy with Dual-Function Peptide S1K and Insulin Reduces Blood Glucose Levels in Mouse Models of Type 1 Diabetes through Beta-Cell Regeneration and Immunosuppression [Board No. 1473]

12:00pm-1:00pm Jun 6 (Central)

Young-Hoon Lee

Presentation

General Poster Session

1474-P - Testosterone Amplifies Glucose-Stimulated Insulin Secretion from Male ß-Cells via Soluble Adenylate Cyclase [Board No. 1474]

12:00pm-1:00pm Jun 6 (Central)

Mirza Muhammad Fahd Qadir

Presentation

General Poster Session

412-P - Acute Hyperglycemia-Induced Endoplasmic Reticulum and Oxidative Stress Increases Monocyte Cholesterol Content and Cytokine Secretion [Board No. 412]

12:00pm-1:00pm Jun 6 (Central)

Rong Mei Zhang

Presentation

General Poster Session

413-P - The Role of Retinol-Binding Protein 4 in the Regulation of Adipocyte Renin-Angiotensin System via Toll-Like Receptor 4 [Board No. 413]

12:00pm-1:00pm Jun 6 (Central)

Kangzhen Zhang, Sr.

Presentation

General Poster Session

387-P - Novel Mitochondrial Complex I Modulator Reduces Diabetes-Associated Expression of Inflammation and Fibrosis Markers in Human Proximal Tubular Epithelial Cells [Board No. 387]

12:00pm-1:00pm Jun 6 (Central)

Karin Jandeleit-Dahm

Presentation

General Poster Session

414-P - Effects of Obesity and Type 2 Diabetes on Cardiac Structure and Arterial Stiffness [Board No. 414]

12:00pm-1:00pm Jun 6 (Central)

Daniel Enge

Presentation

General Poster Session

415-P - Leptin Treatment Has Vasculoprotective Effects in Lipodystrophic Mice [Board No. 415]

12:00pm-1:00pm Jun 6 (Central)

Paulina E Stürzebecher

Presentation

General Poster Session

416-P - Mortality, Major Adverse Cardiovascular Events (MACE) and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes on Long-Term Testosterone Treatment: An Update from a Urological Registry Study [Board No. 416]

12:00pm-1:00pm Jun 6 (Central)

Farid Saad

Presentation

General Poster Session

417-P - Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Children with Type 1 Diabetes (T1D) and Its Association with Arterial Stiffness [Board No. 417]

12:00pm-1:00pm Jun 6 (Central)

Rawah Zeiad

Presentation

General Poster Session

418-P - Certain Patient Subgroups with Type 2 Diabetes May Benefit from Intensive Glycemic and Blood Pressure Control from Reductions in Major Adverse Cardiovascular Events (MACE): A Machine Learning–Based Post Hoc Analysis of ACCORD Trial Data [Board No. 418]

12:00pm-1:00pm Jun 6 (Central)

Hamed Kianmehr

Presentation

General Poster Session

419-P - Chronic Kidney Disease, Type 2 Diabetes, and the Risk of Major Cardiovascular Events in Coronary Artery Disease vs. Peripheral Artery Disease Patients [Board No. 419]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

420-P - Cystatin C Predicts Major Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with Type 2 Diabetes and in Nondiabetic Individuals [Board No. 420]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

421-P - Differential Prognostic Burden of Lower-Limb Amputation and Cardiovascular Disease on the Risk of All-Cause Death in People with Type 1 Diabetes [Board No. 421]

12:00pm-1:00pm Jun 6 (Central)

Marion Camoin

Presentation

General Poster Session

422-P - Predictive Role of Triglyceride-Glucose Index on All-Cause Mortality and Incidence of Vascular Events in Type 2 Diabetes (T2D): A 13-Year Follow-Up Observational Study [Board No. 422]

12:00pm-1:00pm Jun 6 (Central)

Monia Garofolo

Presentation

General Poster Session

423-P - Predictors of Epicardial Adipose Thickness in Overweight and Obese Youth with Type 1 Diabetes [Board No. 423]

12:00pm-1:00pm Jun 6 (Central)

Luke Cielonko

Presentation

General Poster Session

388-P - Renal ROCK2 Activity in Folic Acid-Induced Nephropathy [Board No. 388]

12:00pm-1:00pm Jun 6 (Central)

Kensuke Sekiguchi

Presentation

General Poster Session

491-P - Ten Years of the National Diabetes Prevention Program: Scaling the Lifestyle Change Program across the United States [Board No. 491]

12:00pm-1:00pm Jun 6 (Central)

Elizabeth Ely

Presentation

General Poster Session

424-P - Body-Weight Variability and Risk of Cardiovascular Outcomes in Type 1 Diabetes: Results from the DCCT/EDIC Studies [Board No. 424]

12:00pm-1:00pm Jun 6 (Central)

Iulia Petria

Presentation

General Poster Session

425-P - Lessons Learned from a Patient-Centered, Team-Based Intervention for Patients with Type 2 Diabetes at High Cardiovascular Risk: Year 1 Results from the CINEMA Program [Board No. 425]

12:00pm-1:00pm Jun 6 (Central)

Diamond Berg

Presentation

General Poster Session

427-P - Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Are Mutually Independent Predictors of Major Cardiovascular Events in Patients with Established Cardiovascular Disease [Board No. 427]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

428-P - Type 2 Diabetes Mellitus and Congestive Heart Failure in Women Are Mutually Independent Predictors of Nonalcoholic Fatty Liver Disease [Board No. 428]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

429-P - Pro-B-Type Natriuretic Peptide Strongly Predicts Major Cardiovascular Events and Mortality in Cardiovascular Disease Patients with Type 2 Diabetes as Well as in Those without Diabetes [Board No. 429]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

430-P - Remnant Cholesterol Predicts Major Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with Type 2 Diabetes and in Nondiabetic Individuals [Board No. 430]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

431-P - Waist-to-Body-Mass-Index Ratio and Type 2 Diabetes Mellitus Are Mutually Independent Predictors of Cardiovascular Events in Patients with Coronary Artery Disease [Board No. 431]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

432-P - Single and Joint Impact of Type 2 Diabetes and of Coronary Artery Disease on Albuminuria [Board No. 432]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

433-P - The A Body Shape Index and Type 2 Diabetes Are Mutually Independent Predictors of Major Cardiovascular Events in Patients with Established Cardiovascular Disease [Board No. 433]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

434-P - Patients Hospitalized with Diabetes Mellitus and Underlying Atrial Fibrillation Have Higher Inhospital Mortality and Greater Risk for Cardiac Arrest and Cardiogenic Shock [Board No. 434]

12:00pm-1:00pm Jun 6 (Central)

Michael Fatuyi

Presentation

General Poster Session

389-P - A Six-Month Periodic Fasting Reduces Microalbuminuria and Improves Metabolic Control in Patients with Type 2 Diabetes and Diabetic Nephropathy: A Randomized Controlled Study [Board No. 389]

12:00pm-1:00pm Jun 6 (Central)

Alba Sulaj

Presentation

General Poster Session

492-P - National Diabetes Prevention Program (DPP) Outcomes during the COVID-19 Pandemic, Montana, 2020 Compared with 2017–2019 [Board No. 492]

12:00pm-1:00pm Jun 6 (Central)

Jessie Fernandes

Presentation

General Poster Session

435-P - Sex Differences in Diabetic Cardiovascular Outcomes amongst Patients Admitted for Pneumonia: A Study from the National Inpatient Sample (NIS) [Board No. 435]

12:00pm-1:00pm Jun 6 (Central)

Sarah Leventhal

Presentation

General Poster Session

436-P - Reducing Autoinflammation: The Impact of T-Cell Deficiency on Atherosclerosis [Board No. 436]

12:00pm-1:00pm Jun 6 (Central)

Alyssa J Shepherd

Presentation

General Poster Session

437-P - NOX5 in Human Peripheral Blood Mononuclear Cells Is a Potential Biomarker for Unstable Diabetic Vascular Disease [Board No. 437]

12:00pm-1:00pm Jun 6 (Central)

Tomasz J Block

Presentation

General Poster Session

438-P - Cardiorenal Benefits of Newer Glucose-Lowering Drugs by Hispanic Ethnicity: A Meta-analysis of Results from Randomized Outcome Trials in Type 2 Diabetes [Board No. 438]

12:00pm-1:00pm Jun 6 (Central)

Huilin Tang

Presentation

General Poster Session

439-P - Disparate Effects of Menopause on Cardiovascular Risk in Women with Type 1 Diabetes [Board No. 439]

12:00pm-1:00pm Jun 6 (Central)

Janet K Snell-Bergeon

Presentation

General Poster Session

440-P - Suboptimal Blood Pressure in Adolescents and Young Adults with Type 1 Diabetes: Data from the Australasian Diabetes Data Network (ADDN) Registry [Board No. 440]

12:00pm-1:00pm Jun 6 (Central)

Steven James

Presentation

General Poster Session

441-P - Oleate Prevents Palmitate-Induced Abnormalities in Insulin Signaling in Human Cardiac Progenitor Cells by Inhibiting p38 MAPK and c-Jun Phosphorylation [Board No. 441]

12:00pm-1:00pm Jun 6 (Central)

Francesco Giorgino

Presentation

General Poster Session

442-P - Sorbs2 Deficiency–Mediated Vascular BK Channel Dysfunction in Type 2 Diabetes [Board No. 442]

12:00pm-1:00pm Jun 6 (Central)

Tong Lu

Presentation

General Poster Session

443-P - Structural Echocardiographic Abnormalities in T2D: Mexico Cohort of Take Care of Me Program [Board No. 443]

12:00pm-1:00pm Jun 6 (Central)

Fernando J Lavalle-Gonzalez

Presentation

General Poster Session

444-P - Associations of LDL-C with New-Onset Coronary Artery Disease (CAD) According to HDL-C Levels and Glucose Status [Board No. 444]

12:00pm-1:00pm Jun 6 (Central)

Mayuko H Yamada

Presentation

General Poster Session

390-P - Adipose Insulin Resistance Relates to Perturbed Renal Hemodynamics in Obese Youth with and without Type 2 Diabetes [Board No. 390]

12:00pm-1:00pm Jun 6 (Central)

Carson Platnick

Presentation

General Poster Session

493-P - Medical Assistant Health Coaching for Type 2 Diabetes in Primary Care: A Pragmatic, Cluster-Randomized Controlled Trial [Board No. 493]

12:00pm-1:00pm Jun 6 (Central)

Addie L Fortmann

Presentation

General Poster Session

445-P - CV Risk Factor Control in Patients with T2D and Coronary Artery Disease vs. Stroke [Board No. 445]

12:00pm-1:00pm Jun 6 (Central)

Priyadarshini Balasubramanian

Presentation

General Poster Session

446-P - Lipid Droplet Protein PLIN1 Regulates Inflammatory Polarity in Human Macrophages and Is Involved in Atherosclerotic Plaque Development by Promoting Stable Lipid Storage [Board No. 446]

12:00pm-1:00pm Jun 6 (Central)

Kyuyong Cho

Presentation

General Poster Session

447-P - C/EBPß-Lin28a Positive Feedback Loop Mediated by C/EBPß Hypomethylation Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells in Restenosis [Board No. 447]

12:00pm-1:00pm Jun 6 (Central)

Shan Jiang

Presentation

General Poster Session

448-P - Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes [Board No. 448]

12:00pm-1:00pm Jun 6 (Central)

Russie Allen

Presentation

General Poster Session

449-P - Assessing Cardiovascular Risk in Prediabetes [Board No. 449]

12:00pm-1:00pm Jun 6 (Central)

Teodora Beljic Zivkovic

Presentation

General Poster Session

450-P - Soluble Guanylate Cyclase Stimulator Praliciguat Promotes Ischemic Leg Reperfusion in db/db Mice [Board No. 450]

12:00pm-1:00pm Jun 6 (Central)

Ninon Foussard

Presentation

General Poster Session

451-P - Palmitic Acid–Induced lncRNA PARAIL Regulates Inflammation via Restricting HuR Localization to Cytoplasm in Human Monocytes and Macrophages [Board No. 451]

12:00pm-1:00pm Jun 6 (Central)

Vinay S Tanwar

Presentation

General Poster Session

452-P - Liraglutide Decreases Neointimal Growth in Control and Western Diet–Fed Mice, and Its Effect Is Insulin Dependent [Board No. 452]

12:00pm-1:00pm Jun 6 (Central)

Marel Gonzalez

Presentation

General Poster Session

453-P - Role of JARID2 in Regulating Inflammatory Genes via Epigenetic Mechanisms in Monocyte/Macrophages in Type 2 Diabetes [Board No. 453]

12:00pm-1:00pm Jun 6 (Central)

Marpadga A Reddy

Presentation

General Poster Session

454-P - Association between Insulin and C-Reactive Protein: Data from Athletes and Coronary Angiography Patients [Board No. 454]

12:00pm-1:00pm Jun 6 (Central)

Christoph H Saely

Presentation

General Poster Session

391-P - Normalizing Glomerular Filtration Rate (GFR) Using Extracellular Volume (ECV) Instead of Body Surface Area (BSA): Results from an Analysis of the Preventing Early Renal Loss (PERL) Trial [Board No. 391]

12:00pm-1:00pm Jun 6 (Central)

Leif Erik Lovblom

Presentation

General Poster Session

494-P - Introducing a Patient with Diabetes Experiencing the Social Determinants of Health to Students through Cinematic Virtual Reality [Board No. 494]

12:00pm-1:00pm Jun 6 (Central)

Jana L Wardian

Presentation

General Poster Session

469-P - Sodium–Glucose Cotransporter 2 Inhibitors Decrease the Frequency of Antivascular Endothelial Growth Factor Agent Injection in Patients with Type 2 Diabetes Complicated by Diabetic Macular Edema [Board No. 469]

12:00pm-1:00pm Jun 6 (Central)

Ryoichi Ishibashi

Presentation

General Poster Session

470-P - Mitochondrial Long Noncoding RNA and the Compromised Electron Transport Chain Machinery in Diabetic Retinopathy [Board No. 470]

12:00pm-1:00pm Jun 6 (Central)

Renu Kowluru

Presentation

General Poster Session

471-P - Glycated Haemoglobin in the First Year after Diagnosis of Type 1 Diabetes Is an Independent Risk Factor for Diabetic Retinopathy: The IMDIAB 25 Years Follow-Up Study [Board No. 471]

12:00pm-1:00pm Jun 6 (Central)

Ernesto Maddaloni

Presentation

General Poster Session

472-P - Sex Differences in the Effect of High Serum Uric Acid on the Incidence of Vision-Threatening Retinopathy in Those with Type 2 Diabetes [Board No. 472]

12:00pm-1:00pm Jun 6 (Central)

Masahiko Yamamoto

Presentation

General Poster Session

473-P - Correlation between Serum Elabela and Type 2 Diabetic Retinopathy [Board No. 473]

12:00pm-1:00pm Jun 6 (Central)

Wensha Gu

Presentation

General Poster Session

474-P - Efficacy of Saroglitazar on Diabetes Dyslipidemia with Higher Triglyceride [Board No. 474]

12:00pm-1:00pm Jun 6 (Central)

Ajay Sinha

Presentation

General Poster Session

475-P - Plasma Fatty Acid Composition Is Associated with Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients [Board No. 475]

12:00pm-1:00pm Jun 6 (Central)

Mariko Higa

Presentation

General Poster Session

476-P - Role of TGR5 Signalling in Hepatic Lipid and Lipoprotein Metabolism in Normal and Insulin-Resistant States [Board No. 476]

12:00pm-1:00pm Jun 6 (Central)

Danielle CL Alvares

Presentation

General Poster Session

477-P - Vagal GLP-1–Mediated Reductions in Postprandial Lipids Are Sensitive to Fructose Feeding [Board No. 477]

12:00pm-1:00pm Jun 6 (Central)

Simon S Hoffman

Presentation

General Poster Session

478-P - GALNT2 Variant Associates with Increased ANGPTL3 Circulation Level and Obesity [Board No. 478]

12:00pm-1:00pm Jun 6 (Central)

Alphonse T Thangavel

Presentation

General Poster Session

392-P - Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus [Board No. 392]

12:00pm-1:00pm Jun 6 (Central)

Gregory Gaich

Presentation

General Poster Session

495-P - Fully Immersive Virtual Reality Improves Empathy towards People with Diabetes [Board No. 495]

12:00pm-1:00pm Jun 6 (Central)

Elizabeth A Beverly

Presentation

General Poster Session

479-P - Lipid Pattern in Men with Hypogonadism and Type 2 Diabetes Receiving Long-Term Testosterone Treatment Compared with an Untreated Control Group: Update of a Real-World Registry [Board No. 479]

12:00pm-1:00pm Jun 6 (Central)

Farid Saad

Presentation

General Poster Session

480-P - Correlation of Tg/HDL Ratio and Liver Fibrosis in People with Diabetes in a Tertiary Care Center in India [Board No. 480]

12:00pm-1:00pm Jun 6 (Central)

Ajoy Tewari

Presentation

General Poster Session

481-P - Eligibility for Icosapent Ethyl in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: An Analysis of VERTIS CV [Board No. 481]

12:00pm-1:00pm Jun 6 (Central)

Joseph M Kim

Presentation

General Poster Session

496-P - Biomedical Expertise in the Face of Social Media: How Is Diabetes-Related Information That Stems from Social Media Discussed in Clinical Encounters? [Board No. 496]

12:00pm-1:00pm Jun 6 (Central)

Emilie M Kjærulff

Presentation

General Poster Session

497-P - Ten Years of the National Diabetes Prevention Program: The Effect of Interventions on Priority Population Enrollment [Board No. 497]

12:00pm-1:00pm Jun 6 (Central)

Erin O Landau

Presentation

General Poster Session

393-P - SGLT2 Inhibitors Reduce Cardiovascular and Renal Risks Compared with GLP-1 Receptor Agonists and DPP4 Inhibitors in Patients with Diabetic Kidney Disease: A Systematic Review and Network Meta-analysis [Board No. 393]

12:00pm-1:00pm Jun 6 (Central)

Hongwei Cao

Presentation

General Poster Session

499-P - Optimizing Diabetes Education before Total Pancreatectomy with Islet Cell Autotransplantation (TPIAT) [Board No. 499]

12:00pm-1:00pm Jun 6 (Central)

Rachel E Ellison

Presentation

General Poster Session

500-P - Gaps in Patient Education upon Initial Diabetes Diagnosis among Adults Living with Type 1 and 2 Diabetes in the United States [Board No. 500]

12:00pm-1:00pm Jun 6 (Central)

Emily Xu

Presentation

General Poster Session

502-P - Increasing Provider Referrals to Diabetes Self-Management Education and Support Services: Recommendations from Virtual Focus Groups with Providers in New York State [Board No. 502]

12:00pm-1:00pm Jun 6 (Central)

Rachael Austin

Presentation

General Poster Session

503-P - Online, Interactive Case Study Is Successful at Improving Pharmacists’ Knowledge, Competence, and Confidence Related to Use of CGM and Patient Education in Practice [Board No. 503]

12:00pm-1:00pm Jun 6 (Central)

Amy Larkin

Presentation

General Poster Session

504-P - Success of Aligned Clinician–Patient Education Improves Clinicians’ Ability to Use GLP-1 RAs in Practice and Patients’ Understanding of GLP-1 RAs [Board No. 504]

12:00pm-1:00pm Jun 6 (Central)

Amy Larkin

Presentation

General Poster Session

505-P - Fasting in Ramadan during the Peak of COVID-19 Pandemic: DAFNE Graduates Experience [Board No. 505]

12:00pm-1:00pm Jun 6 (Central)

Abeer K ElSamad

Presentation

General Poster Session

506-P - Project ECHO for Diabetes Improves Physician Assistant Students’ Knowledge and Confidence for Complex Diabetes Care [Board No. 506]

12:00pm-1:00pm Jun 6 (Central)

Megan Phelps

Presentation

General Poster Session

507-P - Eighteen-Month Follow-Up of Peer Support for Diabetes Management in Shanghai Integration Model [Board No. 507]

12:00pm-1:00pm Jun 6 (Central)

Edwin B Fisher

Presentation

General Poster Session

509-P - Trends in Diabetes Self-Management Education and Support Referrals in Kentucky: 2016–2019 [Board No. 509]

12:00pm-1:00pm Jun 6 (Central)

George C Bryant

Presentation

General Poster Session

510-P - DKA Prevention on Insulin Pumps: Lessons Learned from a Large Pediatric Pump Practice [Board No. 510]

12:00pm-1:00pm Jun 6 (Central)

Elizabeth Doyle

Discussion